These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 8634515)
21. [Immunological study on demyelinating peripheral neuropathy. Comparison between experimental allergic neuritis and Guillain-Barré syndrome]. Negishi T Rinsho Shinkeigaku; 1986 Sep; 26(9):891-8. PubMed ID: 3791767 [No Abstract] [Full Text] [Related]
22. [Acute polyradiculoneuropathy of Guillain-Barré. Critical review of potential etiopathogeneses]. Guadagnino M; Petitto F Riv Neurol; 1985; 55(6):402-23. PubMed ID: 3008302 [TBL] [Abstract][Full Text] [Related]
23. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome. Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632 [TBL] [Abstract][Full Text] [Related]
24. Experimental immunology of Guillain-Barré syndrome. Abramsky O; Steiner I Int J Neurol; 1981; 15(3-4):301-13. PubMed ID: 6927600 [No Abstract] [Full Text] [Related]
25. [Value of intravenous immunoglobulins. A case of Guillain-Barré syndrome]. Hidou M; Olivier J; Vivant JF Rev Neurol (Paris); 1992; 148(11):706-8. PubMed ID: 1303562 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1. Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363 [TBL] [Abstract][Full Text] [Related]
27. Animal models for autoimmune demyelinating disorders of the nervous system. Gold R; Hartung HP; Toyka KV Mol Med Today; 2000 Feb; 6(2):88-91. PubMed ID: 10652482 [TBL] [Abstract][Full Text] [Related]
28. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Hartung HP; Reiners K; Schmidt B; Stoll G; Toyka KV Ann Neurol; 1991 Jul; 30(1):48-53. PubMed ID: 1929228 [TBL] [Abstract][Full Text] [Related]
29. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. Hughes RA; Allen D; Makowska A; Gregson NA J Peripher Nerv Syst; 2006 Mar; 11(1):30-46. PubMed ID: 16519780 [TBL] [Abstract][Full Text] [Related]
30. [Guillain-Barré disease: a current treatment method using immunoglobulins]. Kleyweg RP; van der Meché FG Ned Tijdschr Geneeskd; 1992 Oct; 136(40):1956-60. PubMed ID: 1328903 [No Abstract] [Full Text] [Related]
31. [History of Guillain-Barré Syndrome]. Kusunoki S Brain Nerve; 2015 Nov; 67(11):1295-303. PubMed ID: 26560944 [TBL] [Abstract][Full Text] [Related]
32. [Use of intravenous immunoglobulins in Guillain-Barré syndrome]. Ceccarelli M; Assanta N; Chiaravalloti G; Rocopou C; Caiulo VA Minerva Pediatr; 1992 May; 44(5):237-40. PubMed ID: 1620076 [TBL] [Abstract][Full Text] [Related]
35. [Acute inflammatory polyradiculoneuritis during bone marrow transplantation. A report of 2 cases]. Carozzi M; De Manzini A; Giorgi A; Osbich A Pediatr Med Chir; 1994; 16(2):163-5. PubMed ID: 8078793 [TBL] [Abstract][Full Text] [Related]
36. Childhood acute and chronic immune-mediated polyradiculoneuropathies. Rabie M; Nevo Y Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069 [TBL] [Abstract][Full Text] [Related]
37. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin. Soueidan SA; Dalakas MC Pediatr Res; 1993 Jan; 33(1 Suppl):S95-100. PubMed ID: 8433882 [TBL] [Abstract][Full Text] [Related]